Biodexa Pharmaceuticals Plc (BDRX)
Biodexa Pharmaceuticals Plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Biodexa Pharmaceuticals Plc (BDRX) is a Biotechnology company based in GB with a market capitalization of $573.7K. Free cash flow was negative at -$7.2M. This page tracks BDRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
GB · 13 employees · IPO Dec 7, 2015
Valuation
Valuation & price
$3.33as of May 26, 2026· -93.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$573.7K
Market cap
—
Revenue growth (YoY)
-967.5%
Gross margin
-$7.2M
Free cash flow (USD)
-$8.5M
Net debt
Net cash position
-11.4%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2023
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 6-K filed May 14, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 6-K filingJul 9, 2026Filing
General Meeting Notice
- 6-K filingJun 30, 2026Filing
Registered Direct Offering
- 6-K filingJun 30, 2026Filing
Annual General Meeting Results
- 6-K filingJun 30, 2026Filing
Securities Purchase Agreement
- 6-K filingJun 17, 2026Filing
Annual General Meeting Rescheduled
- Annual reportMay 14, 2026Filing
Annual Report Filed
Questions
Frequently asked questions
What is Biodexa Pharmaceuticals Plc's market cap?
Biodexa Pharmaceuticals Plc (BDRX) has a market capitalization of $573.7K.
What is BDRX's P/E ratio?
A meaningful P/E ratio is not available for BDRX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying BDRX stock?
SEC Form 4 filings show no open-market insider buys at Biodexa Pharmaceuticals Plc in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.